BACKGROUND: The purpose of this study was to examine outcomes, toxicity, and dosimetric characteristics of patients treated with reirradiation for head and neck cancers. METHODS: Fifty patients underwent ≥2 courses of radiation therapy (RT) postoperatively or definitively with or without chemotherapy. Composite dose volume histograms (DVHs) for selected anatomic structures were correlated with grade ≥3 late toxicity. RESULTS: Median initial and retreatment radiation dose was 64 and 60 Gy, respectively. Median overall survival (OS), progression-free survival (PFS), and 1-year PFS rates were 18 months, 11 months, and 45%, respectively, with 13 months median follow-up. Thirty-four percent of patients experienced grade ≥3 late toxicity with 1 death from carotid blowout. The DVH corresponding to the carotid blowout fell above the third quartile compared with other patients. CONCLUSION: Our analysis is the first to systematically evaluate the dose to the carotid artery using composite dosimetry in head and neck reirradiation patients, and demonstrates a promising technique for evaluating the dose to other normal tissue structures.
BACKGROUND: The purpose of this study was to examine outcomes, toxicity, and dosimetric characteristics of patients treated with reirradiation for head and neck cancers. METHODS: Fifty patients underwent ≥2 courses of radiation therapy (RT) postoperatively or definitively with or without chemotherapy. Composite dose volume histograms (DVHs) for selected anatomic structures were correlated with grade ≥3 late toxicity. RESULTS: Median initial and retreatment radiation dose was 64 and 60 Gy, respectively. Median overall survival (OS), progression-free survival (PFS), and 1-year PFS rates were 18 months, 11 months, and 45%, respectively, with 13 months median follow-up. Thirty-four percent of patients experienced grade ≥3 late toxicity with 1 death from carotid blowout. The DVH corresponding to the carotid blowout fell above the third quartile compared with other patients. CONCLUSION: Our analysis is the first to systematically evaluate the dose to the carotid artery using composite dosimetry in head and neck reirradiation patients, and demonstrates a promising technique for evaluating the dose to other normal tissue structures.
Authors: Joseph K Salama; Everett E Vokes; Steven J Chmura; Michael T Milano; Johnny Kao; Kirsten M Stenson; Mary Ellyn Witt; Daniel J Haraf Journal: Int J Radiat Oncol Biol Phys Date: 2005-10-05 Impact factor: 7.038
Authors: Felix Zwicker; Falk Roeder; Henrik Hauswald; Christian Thieke; Carmen Timke; Wolfgang Schlegel; Juergen Debus; Marc W Münter; Peter E Huber Journal: Head Neck Date: 2011-01-31 Impact factor: 3.147
Authors: Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre Journal: Head Neck Date: 2005-10 Impact factor: 3.147
Authors: A A Forastiere; T Leong; E Rowinsky; B A Murphy; D R Vlock; R C DeConti; G L Adams Journal: J Clin Oncol Date: 2001-02-15 Impact factor: 44.544
Authors: Sharon A Spencer; Jonathan Harris; Richard H Wheeler; Mitchell Machtay; Christopher Schultz; William Spanos; Marvin Rotman; Ruby Meredith; Kie-Kian Ang Journal: Head Neck Date: 2008-03 Impact factor: 3.147
Authors: Nicolien Kasperts; Ben J Slotman; C Rene Leemans; Remco de Bree; Patricia Doornaert; Johannes A Langendijk Journal: Cancer Date: 2006-04-01 Impact factor: 6.860
Authors: Corey J Langer; Jonathan Harris; Eric M Horwitz; Nicos Nicolaou; Merrill Kies; Walter Curran; Stuart Wong; Kian Ang Journal: J Clin Oncol Date: 2007-10-20 Impact factor: 44.544
Authors: Wouter T C Bots; Sven van den Bosch; Ellen M Zwijnenburg; Tim Dijkema; Guido B van den Broek; Willem L J Weijs; Lia C G Verhoef; Johannes H A M Kaanders Journal: Head Neck Date: 2017-03-06 Impact factor: 3.147